Etudes cliniques

Belgian multicentric ultrasound study in rheumatoid arthritis

A randomized, double-blind, placebo-controlled multicenter phase 2 dose-ranging study to assess the safety and efficacy of multiple VAY736 doses administered subcutaneously in patients with moderate to severe Sjögren's syndrome

A randomized, double-blind, placebo-controlled, multicentre, phase 2 study to assess the efficacy and safety of filgotinib administered for 12 weeks to subjects with active ankylosing spondylitis

MAXIMISE (managing axial manifestations in psorIatic arthritis with secukinumab), a randomized, double-blind, placebo-controlled, multicenter, 52-week study to assess the efficacy and safety of secukinumab 150 mg or 300 mg s.c. in patients with active psoriatic arthritis and axial skeleton involvement who have inadequate response to non-steroidal anti-inflammatory drugs (NSAIDs)

A phase 3, randomized, double-blind, double-dummy, active controlled, multi-center study to evaluate the efficacy and safety of intravenous pegylated liposomal prednisolone sodium phosphate (Nanocort®) compared with intramuscular injection of methylprednisolone acetate in subjects with active rheumatoid arthritis

Bone marrow and blood harvesting for cell therapy research

A two-stage 6-month, multicentre, randomised, double-blind, controlled study on the safety and efficacy of single intra-articular administration of JTA-004 in patients with symptomatic knee osteoarthritis (JTA-KOA1)

A double-blind, randomised, comparative pharmacokinetic, pharmacodynamic, efficacy and safety evaluation of RGB-03 and MabThera® combined with methotrexate in rheumatoid arthritis patients

An observational study in RA patients to evaluate the implementation of recommendations on treating to target (T2T) after DMARD failure in daily practice in Belgium (the BE-T2T study)